Deslauriers J
Department of Surgery, Laval University, Quebec, Canada.
Semin Thorac Cardiovasc Surg. 1996 Jan;8(1):43-51.
Throughout the 20th century, several operations have been advocated as methods of treatment for patients with emphysema and, often, they were promoted as offering potential cures. Unfortunately, most of these procedures attempted to treat the wrong physiological or anatomic deficit so that mid- or long-term results were unpredictable or frankly disastrous. Procedures such as costochondrectomy were designed to permit further enlargement of the lungs, whereas thoracoplasty was designed to reduce lung volume. Operations were performed to restore the curvature of the diaphragm or devised to increase blood supply to the lung. Almost every thoracic structure including chest wall, diaphragm, pleura, nerves, airways, lung, or esophagus became "at risk" for surgical intervention. Short of bullectomy for emphysematous bullous lung disease and perhaps volume reduction for diffuse emphysema, none of these procedures has stood the test of time.
在整个20世纪,有几种手术被提倡作为治疗肺气肿患者的方法,而且它们常常被宣传为有可能治愈。不幸的是,这些手术大多试图治疗错误的生理或解剖缺陷,以至于中长期结果不可预测,或者坦率地说,是灾难性的。诸如肋软骨切除术之类的手术旨在使肺部进一步扩张,而胸廓成形术则旨在减少肺容积。还进行了手术以恢复膈肌的曲度,或者设计手术来增加肺部的血液供应。几乎每个胸部结构,包括胸壁、膈肌、胸膜、神经、气道、肺或食管,都成为了手术干预的“风险对象”。除了针对肺气肿性大疱性肺病的肺大疱切除术以及或许针对弥漫性肺气肿的减容手术外,这些手术都没有经受住时间的考验。